Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-18-008282
Filing Date
2018-12-18
Accepted
2018-12-18 17:11:02
Documents
2
Period of Report
2018-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1710
2 mehtapoa.htm EX-24.1 9896
  Complete submission text file 0001567619-18-008282.txt   13194
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Issuer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AYTU BIOSCIENCE, INC. 373 INVERNESS PARKWAY, SUITE 206 ENGLEWOOD CO 80112
Business Address
Mehta Ketan Bhupatrai (Reporting) CIK: 0001758559 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38247 | Film No.: 181241268